Certificate of Advanced Studies (CAS) in Pharmaceutical Medicine
The Certificate of Advanced Studies (CAS) programme with emphasis on research is focussed on theoretical courses and current projects imparting a profound knowledge in various aspects of pharmaceutical medicine. Students choose 15 or 10 (+ final assignment) out of 19 study units from the Master of Science (MSc) in Pharmaceutical Medicine.
By conducting own research projects students are to develop professional skills in the pharmaceutical sciences which are mainly applicable in the pharmaceutical or pharmacy-related industry and pharmaceutical research institutions.
Degree
Certificate of Advanced Studies (CAS) in Pharmaceutical Medicine, University Duisburg-Essen
Place of study
University Duisburg-Essen, Campus Essen
Start of study
A new study course starts every two years in winter semester (next start: October 2023)
Period of study
The CAS study course covers 1 or 1,5 years and can be conducted while the student is working.
Language
All modules are held in English.
| Degree | Certificate of Advanced Studies (CAS) in Pharmaceutical Medicine |
| University | University Duisburg-Essen |
| Language | All modules are held in English |
| Credits | 25 - 30 ECTS |
| Fees | Version 1: 15 study units: € 12.000,-- (€ 4.000,-- per semester) Version 2: 10 study units + final assignment: € 9.000,-- (€ 4.500,-- per semester) plus Processing Fee of € 125,-- for applications plus Enrolment Fees ( € 45,-- per semester) |
| Duration | Version 1: 3 semesters Version 2: 2 semesters |
| Accreditation and Approval | AQAS, IFAPP, IMI PharmaTrain |
| Requirements | Applicants should have a degree in one of the following areas: • Pharmacy • Life Sciences • Medicine or at least one year's professional experience. |
Basic Information and Application
How is the Certificate of Advanced Studies (CAS) study course structured/duration?
The study course covers one or one and a half year, depending on the version you choose.
Version 1: CAS in Pharmaceutical Medicine, consits of 15 study units in 3 semesters.
Version 2: CAS in Pharmaceutical Medicine consits of 10 study units + final assignment
Which entrance requirements exist for the MSc study course?
Applicants should have an academic degree in one of the following areas:
- Pharmacy
- Life Sciences
- Medicine
or one year's professional experience.
Which language is used in the CAS study course?
All modules are held in English.
How much does it cost to participate in the CAS study course?
- Certificate of Advanced Studies in Pharmaceutical Medicine (15 study units): € 12.000,-- (€ 4.000,-- per semester)
- Certificate of Advanced Studies in Pharmaceutical Medicine (10 study units + final assignment): € 9.000,-- (€ 4.500,-- per semester)-
How to apply for the CAS study course?
Interested persons can apply in writing at the
Examination board “MSc of Pharmaceutical Medicine”
c/o Ruhr Campus Academy (RCA) gGmbH
Frau Vanessa Foschepoth
Edmund-Körner-Platz 2
45127 Essen
Germany
or by Email at vanessa.foschepoth[at]rca.uni-due.de
The application must contain the following documents additionally to the application form:
- completed application form with a passport sized photograph
- typed curriculum vitae, not exeeding 3 pages and emphasis should be placed on your employment history
- degree certificate
- proof/certificate of employment
Processing Fee of € 125,-- for applications
Application documents assessed by the Scientific Course Committee (SCC) as promising will lead to an invitation for interviews. The interviewers will be lecturers from the study course. Naturally the interview will be – at least partly – in English.
For the interview we would like you to tell us about your work and study experiences, insights, career objectives and aims. There are no specific requirements for the interview; it is a chance for you to talk about yourself, for you to meet us and also a chance for you to see what the University of Duisburg-Essen offers.
Members of the Scientific Course Committee
Dr. Dr. Holger Adelmann (Chairman)
Prof. Dr. Dobromir Dobrev, Universität Duisburg-Essen
Prof. Dr. Karl-Heinz Jöckel, Universität Duisburg-Essen
Prof. Dr. Kristina Lorenz, ISAS e.V.
Prof. Dr. Martin Michel, Johannes Gutenberg-Universität Mainz
Dr. Peter Schüler (vice-Chairman), ICON Clinical Research GmbH
Study Course Pharmaceutical Medicine
Study Course Pharmaceutical Medicine
| No. | Study Unit | Module | Date | |
|---|---|---|---|---|
| 01 | General Introduction to the Health System and the Pharmaceutical Industry | Fundamental Principles and Tools | 07th – 09th October 2021 | Karsten Sternberg Dr. Peter Schüler |
| 02 | Working in a Complex Organization | Fundamental Principles and Tools | 04th – 06th November 2021 | Karsten Sternberg Dr. Peter Schüler |
| 03 | Project Management | Fundamental Principles and Tools | 2nd – 04th December 2021 | |
| 04 | Health Economics | Fundamental Principles and Tools | 13th – 15th January 2022 | Dr. Charalabos-Markos Dintsios Dr. Jochen Fleischmann |
| 05 | International Health Systems and Market Access | Fundamental Principles and Tools | 10th – 12th February 2022 | Dr. Charalabos-Markos Dintsios Dirk Kars |
| 06 | Drug Discovery and Development | Pharmaceutical New Product Development | 10th – 12th March 2022 | Dr. Christian Leuner Dr. Martin Zoche |
| 07 | Biopharmaceuticals and -technology | Pharmaceutical New Product Development | 07th – 09th April 2022 | Dr. Berthold Bödeker |
| 08 | Toxicology (including Safety Pharmacology and Toxicokinetics) | Pharmaceutical New Product Development | 05th – 07th May 2022 | Prof. Dr. Gerd Bode |
| 09 | Clinical Pharmacology and Pharmacokinetics | Pharmaceutical New Product Development | 09th – 11th June 2022 | Dr. Dr. med. Holger Adelmann |
| 10 | Clinical Trials | Pharmaceutical New Product Development | 18th – 20th August 2022 | Dr. Peter Schüler |
| 11 | Strategies and Managing Clinical Trials | Pharmaceutical New Product Development | 22nd – 24th September 2022 | Dr. Klaus-Gustav Beinhauer Dr. Birgit Ruhfus |
| 12 | Ethical and Legal Issues in Drug Development | Pharmaceutical New Product Development | 20th – 22nd October 2022 | Dr. Ferdinand Hundt Dr. Matthias Klüglich |
| 13 | Clinical Systems and Data Management | Pharmaceutical New Product Development | 17th – 19th November 2022 | Dr. Johann Pröve Martin Probach |
| 14 | Biostatistics | Pharmaceutical New Product Development | 15th – 17th December 2022 | Dr. Stefan Hantel Martin Roessner |
| 15 | Drug Safety | Patients and Markets | 12th – 14th January 2023 | Dr. Sabine Richter Yvonne Nanciu MD(RO), MSc |
| 16 | Post-Marketing Surveillance | Patients and Markets | 09th – 11th February 2023 | Dr. Mohamed Salem |
| 17 | Regulatory Affairs | Patients and Markets | 09th – 11th March 2023 | Mohamed Adib Dr. Rüdiger Faust |
| 18 | Marketing and Sales | Patients and Markets | 20th – 22nd April 2023 | Martin Obladen Dr. med. Günter Umbach |
| 19 | Pharmaceutical Related Case Studies | Patients and Markets | 25th – 27th May 2023 | Martin Roessner Dr. Peter Schüler |
contact
Vanessa Foschepoth
Tel.: +49 (0) 201 / 183 - 7393
Mail: vanessa.foschepoth@rca.uni-due.de